- Lobbying
- John AND Buckley
Lobbying Arrangements Results for 'John Buckley'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Effect of tax reform on domestic manufacturing |
Alliance for American Manufacturing
|
Mr. John L Buckley | |||
Details Investments in US assets by sovereign wealth fund. |
Grafton Strategies
Strategic communications. |
Mr. John Buckley | |||
Details Implementation of Average Sales Price (ASP) Methodology; exclusion of prompt pay discounts from ASP; H.R. 1392 |
SPECIALTY & BIOTECH DISTRIBUTORS ASSOCATION
|
SIDLEY AUSTIN LLP | |||
Details Access to prescription drugs and payment/reimbursement related issues, including patient access under Medicare Part D. |
Sunovion Pharmaceuticals Inc.
|
SIDLEY AUSTIN LLP | |||
Details -Medicaid rare disease patient access to therapy Patient access to therapy, including Medicaid, Medicare, and insurance. -Orphan Drug Act regulations -Expanded Access -Rare Disease awareness -Newbo... |
Shire Pharmaceuticals LLC
|
in-house lobbying | |||
Details General issues related to Basel III notice of proposed rulemaking and regulatory capital. General issues related to credit card late fee notice of proposed rulemaking. HR 3881/S 1838, Credit Card C... |
BANK OF AMERICA CORPORATION
|
in-house lobbying | |||
Details FDA modernization policy issues Reauthorization of newborn screening programs General issues related to rare disease and orphan drugs General issues related to health equity in rare disease and ... |
AstraZeneca Pharmaceuticals LP
|
in-house lobbying | |||
Details H.R. 4368: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 5893: Commerce, Justice, Science, and Related Agencies Appropriations Act... |
Pharmaceutical Research and Manufacturers of America
|
in-house lobbying | |||
Details Antibiotic Use in Livestock ---H.R.4012: To repeal the guidance titled "CVM GFI #263 Recommendations for Sponsors of Medically Important Antimicrobial Drugs Approved for Use in Animals to Voluntar... |
Biotechnology Innovation Organization
|
in-house lobbying |